{"title":"更正“采用新治疗方案管理的TEN/SJS系列回顾性评估”。","authors":"","doi":"10.1111/jdv.20892","DOIUrl":null,"url":null,"abstract":"<p>Steinhoff M, Buddenkotte J, Al-Shafi W, Al-Marri H, Emam F, Iqneibi M, Harris TRE, Thomas SH, Asad SM, Al-Maslamani H, Joy FE, Therachiyil L, Jochebeth A, Leo R, Younis SM, Abu Raddad LJ, Dargham SR, Al-Khawaga S. Retrospective evaluation of a TEN/SJS series managed with a new treatment protocol. <i>J Eur Acad Dermatol Venereol</i>. 2025;39:e42–5.</p><p>In the ‘Funding Information’ section, the text ‘Supported by MRC Fund #MRC-01-21-763, Hamad Medical Corporation, Qatar (to M.S., J.B. and S.A.K.)’ was incorrect. This should have read ‘Supported by MRC Fund #MRC-01-21-736, Hamad Medical Corporation, Qatar (to M.S., J.B. and S.A.K.)’.</p><p>In addition, in the ‘Ethical Approval’ section, an incorrect approval number #MRC-01-21-763 was reported. The correct ethical approval number is #MRC-01-21-736.</p><p>We apologize for this error.</p>","PeriodicalId":17351,"journal":{"name":"Journal of the European Academy of Dermatology and Venereology","volume":"39 10","pages":""},"PeriodicalIF":8.0000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.20892","citationCount":"0","resultStr":"{\"title\":\"Correction to ‘Retrospective evaluation of a TEN/SJS series managed with a new treatment protocol’\",\"authors\":\"\",\"doi\":\"10.1111/jdv.20892\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Steinhoff M, Buddenkotte J, Al-Shafi W, Al-Marri H, Emam F, Iqneibi M, Harris TRE, Thomas SH, Asad SM, Al-Maslamani H, Joy FE, Therachiyil L, Jochebeth A, Leo R, Younis SM, Abu Raddad LJ, Dargham SR, Al-Khawaga S. Retrospective evaluation of a TEN/SJS series managed with a new treatment protocol. <i>J Eur Acad Dermatol Venereol</i>. 2025;39:e42–5.</p><p>In the ‘Funding Information’ section, the text ‘Supported by MRC Fund #MRC-01-21-763, Hamad Medical Corporation, Qatar (to M.S., J.B. and S.A.K.)’ was incorrect. This should have read ‘Supported by MRC Fund #MRC-01-21-736, Hamad Medical Corporation, Qatar (to M.S., J.B. and S.A.K.)’.</p><p>In addition, in the ‘Ethical Approval’ section, an incorrect approval number #MRC-01-21-763 was reported. The correct ethical approval number is #MRC-01-21-736.</p><p>We apologize for this error.</p>\",\"PeriodicalId\":17351,\"journal\":{\"name\":\"Journal of the European Academy of Dermatology and Venereology\",\"volume\":\"39 10\",\"pages\":\"\"},\"PeriodicalIF\":8.0000,\"publicationDate\":\"2025-07-31\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jdv.20892\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of the European Academy of Dermatology and Venereology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1111/jdv.20892\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"DERMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of the European Academy of Dermatology and Venereology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jdv.20892","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"DERMATOLOGY","Score":null,"Total":0}
引用次数: 0
摘要
Steinhoff M, Buddenkotte J, Al-Shafi W, Al-Marri H, Emam F, Iqneibi M, Harris TRE, Thomas SH, Asad SM, Al-Maslamani H, Joy FE, Therachiyil L, Jochebeth A, Leo R, Younis SM, Abu Raddad LJ, dagham SR, Al-Khawaga S. TEN/SJS系列治疗方案的回顾性评估。中国生物医学工程学报,2015;39(5):442 - 456。在“资助信息”部分,文本“由MRC基金#MRC-01-21-763,哈马德医疗公司,卡塔尔(给ms, J.B.和S.A.K.)支持”是不正确的。这条应该是“MRC基金支持,MRC-01-21-736,哈马德医疗公司,卡塔尔(给m.s., J.B.和S.A.K.)”。此外,在“伦理批准”部分,报告了错误的批准号#MRC-01-21-763。正确的伦理批准号是#MRC-01-21-736。我们为这个错误道歉。
Correction to ‘Retrospective evaluation of a TEN/SJS series managed with a new treatment protocol’
Steinhoff M, Buddenkotte J, Al-Shafi W, Al-Marri H, Emam F, Iqneibi M, Harris TRE, Thomas SH, Asad SM, Al-Maslamani H, Joy FE, Therachiyil L, Jochebeth A, Leo R, Younis SM, Abu Raddad LJ, Dargham SR, Al-Khawaga S. Retrospective evaluation of a TEN/SJS series managed with a new treatment protocol. J Eur Acad Dermatol Venereol. 2025;39:e42–5.
In the ‘Funding Information’ section, the text ‘Supported by MRC Fund #MRC-01-21-763, Hamad Medical Corporation, Qatar (to M.S., J.B. and S.A.K.)’ was incorrect. This should have read ‘Supported by MRC Fund #MRC-01-21-736, Hamad Medical Corporation, Qatar (to M.S., J.B. and S.A.K.)’.
In addition, in the ‘Ethical Approval’ section, an incorrect approval number #MRC-01-21-763 was reported. The correct ethical approval number is #MRC-01-21-736.
期刊介绍:
The Journal of the European Academy of Dermatology and Venereology (JEADV) is a publication that focuses on dermatology and venereology. It covers various topics within these fields, including both clinical and basic science subjects. The journal publishes articles in different formats, such as editorials, review articles, practice articles, original papers, short reports, letters to the editor, features, and announcements from the European Academy of Dermatology and Venereology (EADV).
The journal covers a wide range of keywords, including allergy, cancer, clinical medicine, cytokines, dermatology, drug reactions, hair disease, laser therapy, nail disease, oncology, skin cancer, skin disease, therapeutics, tumors, virus infections, and venereology.
The JEADV is indexed and abstracted by various databases and resources, including Abstracts on Hygiene & Communicable Diseases, Academic Search, AgBiotech News & Information, Botanical Pesticides, CAB Abstracts®, Embase, Global Health, InfoTrac, Ingenta Select, MEDLINE/PubMed, Science Citation Index Expanded, and others.